PLAY PODCASTS
Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes
Episode 116

Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes

Join Dr. Amy DeZern, Dr. Daniel Pollyea, and Dr. Amer Zeidan as they discuss their treatment strategies for 3 patients with myelodysplastic syndromes.

Decera Clinical Education Oncology Podcast · Amy E. DeZern MD MHS, Daniel Pollyea MD MS, Amer Zeidan MBBS

March 14, 202228m 6s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, including

  • Treatment for MDS after ESA failure
  • Strategies for patients with intermediate- or high-risk MDS
  • Luspatercept therapy in MDS
  • MDS case challenges

Link to full program, including downloadable slidesets:
https://bit.ly/3tYwcYu

Presenters: 
Amy E. DeZern, MD, MHS
Associate Professor
Oncology and Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Daniel Pollyea, MD, MS
Associate Professor of Medicine
Clinical Director of Leukemia Services
Division of Hematology
University of Colorado School of Medicine
Aurora, Colorado

Amer Zeidan, MBBS
Associate Professor, Internal Medicine
Hematology
Yale University
New Haven, Connecticut


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

decitabinehematologic malignancieshypomethylating agentsmyelodysplastic syndromesazacitidinehmasluspaterceptmdsstem cell transplant